Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
152 participants
OBSERVATIONAL
2006-05-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Links Between OCD and Anorexia
NCT02085057
Appetite-Related Brain Activity in Women With Anorexia Nervosa
NCT00344656
Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa
NCT02615119
Functional Magnetic Resonance Imaging (fMRI) Imaging Study in Adolescents With Anorexia Nervosa
NCT00978666
Comparing Neural Responses to Food Images in EDNOS Patients and Healthy Controls Using fMRI
NCT01882023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anorexia nervosa
Individuals with anorexia nervosa receiving inpatient treatment
No interventions assigned to this group
Healthy controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 16-45;
* Inpatient on GCRU
* Medically stable.
Exclusion:
* Any other current major Axis I disorder (including current bulimia nervosa), except major depression;
* History of concussion, seizure disorder, or other neurological illness;
* History of learning disability;
* Acute Suicidality
Healthy comparison group:
Inclusion:
* No current or past psychiatric illness;
* Age 16-45
* No history of binge eating or vomiting;
* Normal weight (80%-120% ideal body weight)
Exclusion:
* Significant medical or neurologic illness(concussion, seizure disorder, learning disability, other neurological illness)
* Current psychotropic medication or medications known to impact cognition
Exclusion Criteria
* Pregnancy
* Indwelling metallic object, non-removable metal jewelry, medicinal patch or recent metallic ink tattoo
* For patients, current psychotropic medications (antidepressants for 2 week (prozac and antipsychotics for 4 weeks)
* For patients, any other current Axis I diagnosis
16 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klarman Family Foundation
UNKNOWN
National Institute of Mental Health (NIMH)
NIH
New York State Psychiatric Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanna Steinglass, MD
Role: PRINCIPAL_INVESTIGATOR
New York State Psychiatric Institute
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
#5984R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.